This page includes the latest FDA filings for Boston Biopharma. Currently, you will find the latest 100 filings for Premarket Notifications, Premarket Applications, De Novo Applications, and GUDID registrations.
| Registration Number | 3016655201 |
| FEI Number | 3016655201 |
| Name | BOSTON BIOPHARMA |
| Owner & Operator | Boston Biopharma |
| Contact Address | 570 Colonial Park Dr #309 Roswell GA 30075 US |
| Official Correspondent |
|
| Registration Status | 1 |
| Initial Importer | Y |
| Registration Expiration | 2020-04-25 |
| Registration Address | 570 Colonial Park Dr #309 Roswell, GA 30075 US |
| Establishment Type | Repack or Relabel Medical Device |
Device Company | Device | Date |
|---|---|---|
| Boston Biopharma, Halocarbon Life Sciences, LLC, Pharmasol Corporation | Prescription Medication | 2020-09-11 |
| Boston Biopharma, Halocarbon Life Sciences, LLC, Pharmasol Corporation | Prescription Medication | 2020-05-20 |
BOSTON BIOPHARMA | PROTECTIVE MASK KN95 | 2020-04-10 |
BOSTON BIOPHARMA | BB Rapid-TQ Coronavirus (SARS-CoV-2) Test kit (Lateral flow method) | 2020-03-30 |
BOSTON BIOPHARMA | BB Rapid-MX Novel Coronavirus (SARS-CoV-2) IgG/IgM Antibody Detection Kit (Colloidal Gold) | 2020-03-30 |
| Boston Biopharma | Sevoflurane Bostonbio | 2020-03-27 |
| Boston Biopharma, Halocarbon Life Sciences, LLC, Pharmasol Corporation | Prescription Medication | 2020-03-27 |